Reflection piece by: Siripong Srichau
Digital Key Population Engagements Officer, APCOM
The AIDS2024 conference, held in Munich, Germany, from July 20 to July 26, 2024, brought together global experts, policymakers, community leaders, and activists to address the ongoing challenges and opportunities in the fight against HIV/AIDS. The conference served as a crucial platform for advancing global health, fostering innovative solutions, and promoting human rights, with a particular focus on key populations disproportionately affected by the epidemic.
With support from the United Nations Office on Drugs and Crime (UNODC), APCOM Foundation participated in this conference to strengthen its mission of advocating for the health and human rights of marginalized communities in Asia and the Pacific, particularly those affected by HIV/AIDS. APCOM’s participation aimed to engage with international stakeholders, exchange knowledge, and explore the latest advancements and strategies in HIV prevention, treatment, and advocacy.
By participating in various sessions, activities at the Global Village, and conducting interviews with community members, the objective was to gather insights that align with and inform both APCOM’s and UNODC’s missions, particularly in relation to health, criminal justice, and human rights.
This report aims to provide a comprehensive overview of the key sessions, community engagements, and findings from the AIDS2024 conference, highlighting the implications for UNODC’s and APCOM’s ongoing efforts in promoting public health, human rights, and social justice.
Conference Overview
At the AIDS2024 conference, the sessions I attended provided valuable insights into integrated healthcare approaches for vulnerable populations, lessons from implementing HIV prevention programs like Pre-Exposure Prophylaxis (PrEP), the potential of Artificial Intelligence (AI) in healthcare, emerging drug use patterns, harm reduction in challenging settings, the integration of social enterprise for key populations (KPs), and managing comorbidities in people living with HIV. These sessions align closely with APCOM’s mission to support HIV prevention and treatment among key populations in Asia-Pacific and UNODC’s focus on health and human rights for marginalized communities, particularly those affected by drugs and incarceration.
The first session emphasized a person-centered, integrated healthcare model in Eastern Europe and Central Asia (EECA), focusing on multi-drug resistant tuberculosis (MDR-TB) and the role of community-led responses in addressing barriers to healthcare for people living with TB and HIV. Challenges in prisons, particularly the lack of access to essential health services, were highlighted, with examples from Ukraine and Moldova showcasing successful harm reduction and social support initiatives. This session’s relevance to APCOM and UNODC lies in its focus on providing healthcare access to key populations, including people who use drugs and those in prison.
In the second session on PrEP delivery for young people, projects in South Africa and Brazil highlighted how decentralized and youth-friendly services improved access to HIV prevention for adolescent girls, young women, men who have sex with men (MSM), and transgender women (TGW). The use of peer-driven recruitment, mental health support, and integration of sexual health services was key to success.
The third session explored the role of AI in healthcare, particularly for improving HIV diagnostics and personalizing care. AI’s potential to enhance treatment outcomes and address health inequities in vulnerable populations is an emerging field that could offer new tools for digital health initiatives.
Emerging patterns in drug use were the focus of the fourth session, where studies from Kyrgyzstan and Zimbabwe explored risky behaviors associated with new psychoactive substances (NPS) and injection drugs. The need for combining harm reduction and sexual health services to address HIV risks among drug users was emphasized.
The fifth session on harm reduction successes in challenging settings showcased how peer-led interventions effectively reduced substance use among young transgender women in Brazil.
Session six focused on integrating social enterprise for the sustainability of key population programs. Presentations from Kenya, Thailand, and India demonstrated how social enterprises could ensure the long-term sustainability of HIV services for key populations.
The final session on managing comorbidities in people living with HIV explored the relationship between HIV viremia and cardiovascular disease (CVD). Studies showed no direct link between HIV viral load and CVD risk, but they emphasized the importance of monitoring ART side effects like hypertension.
In conclusion, the sessions at AIDS2024 provided a wealth of knowledge that is directly applicable to both APCOM and UNODC’s work. From community-led healthcare models and innovative approaches to PrEP delivery to the integration of social enterprise and harm reduction services, these insights reinforce the importance of comprehensive, sustainable interventions for key populations. Both organizations can leverage these findings to enhance HIV prevention and care for marginalized groups, particularly in regions like Asia-Pacific, where access to healthcare remains a challenge for many.
Global Village Activities
At the Global Village during AIDS2024, I had the opportunity to immerse myself in several engaging activities. I participated in community workshops and discussions, where we tackled important topics like HIV prevention, sexual health, and human rights advocacy. These sessions provided a valuable platform for knowledge exchange and connecting with others passionate about these issues. One of the highlights for me was attending cultural events and performances, which celebrated diversity and inclusion in a truly vibrant way. Additionally, I joined networking sessions where I connected with other organizations and explored potential collaborations for future initiatives. These experiences were not only insightful but also provided a strong sense of community engagement and solidarity.
Conclusion
The AIDS2024 conference provided APCOM and UNODC with invaluable insights into the global landscape of HIV prevention, treatment, and advocacy, particularly for key populations. The key findings from sessions on person-centered healthcare models, harm reduction, and social enterprises underscored the critical role of community-led initiatives and sustainable interventions in addressing the health needs of marginalized groups. These learnings reinforce the significance of APCOM’s mission and align with UNODC’s focus on promoting health and human rights for people affected by drugs.
UNODC’s support was instrumental in enhancing APCOM’s advocacy efforts, enabling meaningful participation in sessions that directly informed our strategies for supporting key populations. Through community engagement and global collaboration, APCOM has strengthened its ability to advocate for inclusive healthcare, social justice, and the rights of vulnerable communities in the Asia-Pacific region. The knowledge gained from this conference will guide future projects and initiatives, contributing to more effective, evidence-based interventions.
Looking ahead, APCOM plans to deepen its collaboration with UNODC, particularly in the areas of drug use and harm reduction, expanding access to healthcare for key populations, and advocating for policy changes that ensure equity and justice. Further collaboration could explore integrating digital health tools and social enterprise models to build sustainable, community-led programs that advance global health and human rights.
